Membership Directory

Novozymes Biopharma US

Category: Research Products and Instrumentation
Phone: 617-401-2500
Fax: 617-401-2501
Website: http://www.biopharma.novozymes.com

Novozymes Biopharma US, Inc. is responsible for carrying out commercial global sales of biopharmaceutical ingredients on behalf of Novozymes A/S. Novozymes delivers scientifically proven recombinant products for mammalian cell culture and protein drug formulation, and is the pioneer of yeast based protein expression and albumin fusion technology. From product to process, Novozymes encompasses a set of integrated capabilities and expertise that offers valuable alternatives in the development and manufacture of biopharmaceutical products. Our commercial sales team works directly with customers to offer recombinant animal free, regulatory compliant solutions for the biopharmaceutical industry that are manufactured by Novozymes’ 3 subsidiaries - Novozymes Biopharma SE AB, Novozymes Biopharma UK Ltd and Novozymes Biopharma AU Ltd. Our recombinant product offerings currently include: Recombumin® , albucult™, CellPrime™rAlbumin AF, LONG®R3IGF-I, LONG®EGF, LONG®TGF-α, and CellPrime™rTransferrin AF Novozymes’ Biopharma, U.S. Inc., is a wholly owned subsidiary of Novozymes A/S. Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow’s industrial biosolutions, improving our customers' business and the use of our planet's resources. With over 700 products used in 130 countries, Novozymes’ bioinnovations improve industrial performance and safeguard the world’s resources by offering superior and sustainable solutions for tomorrow’s ever-changing marketplace. Read more at www.novozymes.com.

Back to list

Recent Jobs